Market Overview

Mark Cuban Thinks Amazon, Berkshire, JPMorgan Collab Could Pressure Congress To Act

Share:
Mark Cuban Thinks Amazon, Berkshire, JPMorgan Collab Could Pressure Congress To Act
Related AMZN
Benzinga's Week Ahead: Can Tech Earnings Restore The Rally? Amazon, Google To Report
Upcoming Earnings: Telecom Giants Verizon And AT&T Report This Week
Make CBL Great Again (Seeking Alpha)
Related JPM
Insider Buys Of The Week: FedEx, JPMorgan And More
Barron's Picks And Pans: Alibaba, Citizens Financial, FAANG Stocks And More
Banks see customers pull billions from accounts that don't pay interest: WSJ (Seeking Alpha)

U.S. health care seems to have met its match — and so has the U.S. government.

A power team of Amazon.com, Inc. (NASDAQ: AMZN), JPMorgan Chase & Co. (NYSE: JPM) and Berkshire Hathaway Inc. (NYSE: BRK-A) announced Tuesday a collaboration to address the health care needs of their domestic employees, and Mark Cuban thinks the disturbance could soon rattle the halls of Congress.

“Change will come from people outside the government creating compelling solutions that force bipartisanship,” Cuban told Benzinga.

'Smart People Solving Problems'

By his assessment, the private partnership of CEOs Jamie Dimon, Jeff Bezos and Warren Buffett could prod Congress to accelerate reform.

"This is not about private versus public sector,” Cuban said. “Business versus government is not a binary decision. This is about smart people focusing on solving problems.”

Be the first to get this news with Benzinga Pro. Sign up for your free two-week trial here.

The Amazon-JPMorgan-Berkshire collaborative seems aware of its influence. The group made clear its aims to simplify, improve the quality of and reduce the cost of employee health care by leveraging its combined power.

"The three of our companies have extraordinary resources, and our goal is to create solutions that benefit our U.S. employees, their families and, potentially, all Americans,” Dimon said in a press release.

No New Ground Broken

Details are yet uncertain, and while corporate efforts may pressure action, Cowen believes the trio’s targets align with those already being discussed in Washington and aren’t necessarily disruptive.

In other words, they may inspire a change in pace, but not necessarily direction.

“In our view the commentary from these companies about the goals/desires for its new health care entity doesn’t seem to break any new ground in the debate over rising health care costs,” analysts Charles Rhyee, Christine Arnold and John Blackledge wrote in a note. “Certainly, it signals the entry of a very, very well capitalized participant, but the language in setting out the vision for the new entity doesn’t look to make wholesale changes to the health care market.”

The parties will announce a management team, headquarters and operational details in the future.

Several pharmacy-benefit managers and health insurance stocks sold off big following the release. UnitedHealth (NYSE: CVS), Cigna (NYSE: CI), and CVS Health (NYSE: CVS), among others, were down as much as 5 percent Tuesday morning.

Related Links:

Amazon's Pharma Aspirations: Cowen Finds No New License Applications

Morgan Stanley: Health Care M&A Means Headwinds For Hospitals

Image credit: TechCrunch - 509306865DH00026_TechCrunch, CC BY 2.0, via Wikimedia Commons

Posted-In: Jamie DimonAnalyst Color News Health Care Politics Top Stories Exclusives General Best of Benzinga

 

Related Articles (AMZN + BRK-A)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ETTXWedbushInitiates Coverage On19.0
WINGWedbushDowngrades0.0
BMYCitigroupDowngrades57.0
INTCNomuraUpgrades0.0
HRZNKeefe Bruyette & WoodsDowngrades10.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Mid-Day Market Update: Crude Oil Down 2%; Thomson Reuters Shares Spike Higher

Global Appeal In A Generics ETF